In a mouse model of transient MCAO, inhibiting C3 activity via genetic knockout or antioxidant N-tert-butyl-α-phenylnitrone treatment could alleviate inflammatory response, reduce brain infarct volume, and attenuate neurological deficiency following 1 to 7 days of brain ischemia. The gene discussed is C3; the disease is brain ischemia.